France: Archimed moves to consolidate purity testing with purchase of Carso

Private equity healthcare specialist, ArchiMed, has acquired a majority stake in Lyon-based Carso, France’s leader in purity testing in pharma, healthcare, the environment, food and other fields. The purchase was made through its €1bn MED Platform I fund. In partnership with Capza, Siparex, and Carso’s managers and founders, ArchiMed plans to play a major role…

You must be a HMI Subscriber to view this content.

Subscribe Now »